Please login to the form below

Not currently logged in
Email:
Password:

Judith Cranford joins Ruder Finn

PR agency, Ruder Finn has announced the appointment of Judith Cranford as MD of health, advocacy and alliance development for its London office

PR agency, Ruder Finn has announced the appointment of Judith Cranford as MD of health, advocacy and alliance development for its London office.

Cranford joins from global communications firm, MS&L Worldwide where, as MD of health and advocacy, she was involved in managing European and global programmes for pharmaceutical and medical device companies, as well as non-governmental organisations.

Her past roles have included CEO of the National Osteoporosis Foundation (NOF) in Washington, DC. In this advocacy role, Cranford helped raise awareness of osteoporosis as a significant public health concern as part of her responsibilities to lead efforts in increasing understanding of the prevention, diagnosis and treatment of the bone disease.

She also has previous experience with Ruder Finn as healthcare business group director.

"Judith's international background and extensive experience in advocacy, alliance management and corporate social responsibility is significant to much of our healthcare work at Ruder Finn, both for corporate and non-profit clients," said Nick Leonard, MD for Ruder Finn London. "The strategic insight and leadership experience she brings is vital to successfully addressing the interests of industry, patients and healthcare professionals, particularly around access."

Cranford's new role will involve advancing Ruder Finn's activities in areas of pharmaceuticals, life sciences, global advocacy and public affairs, as well as innovating new strategies in emerging client challenges such as market access and the implications of social media in healthcare.

"Ruder Finn has a strong heritage in all aspects of healthcare communications," said Cranford. "I look forward to working with colleagues as we continue to evolve the practice. We want to support our clients by providing the ongoing creativity, strategic and innovative counsel that helps them to effectively address the diverse challenges of a complex and constantly changing health landscape."

13th May 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...
Planning your clinical trial? Why you need to engage patients sooner
It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....

Infographics